These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35612198)

  • 1. Towards a Computational Approach for the Assessment of Compliance of ALCOA+ Principles in Pharma Industry.
    Durá M; Sánchez-García Á; Sáez C; Leal F; Chis AE; González-Vélez H; García-Gómez JM
    Stud Health Technol Inform; 2022 May; 294():755-759. PubMed ID: 35612198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provable Data Integrity in the Pharmaceutical Industry Based on Version Control Systems and the Blockchain.
    Steinwandter V; Herwig C
    PDA J Pharm Sci Technol; 2019; 73(4):373-390. PubMed ID: 30770485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data Integrity: History, Issues, and Remediation of Issues.
    Rattan AK
    PDA J Pharm Sci Technol; 2018; 72(2):105-116. PubMed ID: 29158286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data integrity within the biopharmaceutical sector in the era of Industry 4.0.
    Alosert H; Savery J; Rheaume J; Cheeks M; Turner R; Spencer C; S Farid S; Goldrick S
    Biotechnol J; 2022 Jun; 17(6):e2100609. PubMed ID: 35318814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study.
    Tauqeer F; Myhr K; Gopinathan U
    Health Policy Plan; 2019 Jul; 34(6):440-449. PubMed ID: 31302684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Blockchain Technology in the Health Care Sector: Systematic Review.
    Elangovan D; Long CS; Bakrin FS; Tan CS; Goh KW; Yeoh SF; Loy MJ; Hussain Z; Lee KS; Idris AC; Ming LC
    JMIR Med Inform; 2022 Jan; 10(1):e17278. PubMed ID: 35049516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockchain Reference System Architecture Description for the ISA95 Compliant Traditional and Smart Manufacturing Systems.
    Yalcinkaya E; Maffei A; Onori M
    Sensors (Basel); 2020 Nov; 20(22):. PubMed ID: 33198154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockchain Medledger: Hyperledger fabric enabled drug traceability system for counterfeit drugs in pharmaceutical industry.
    Uddin M
    Int J Pharm; 2021 Mar; 597():120235. PubMed ID: 33549813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data mining in pharma sector: benefits.
    Ranjan J
    Int J Health Care Qual Assur; 2009; 22(1):82-92. PubMed ID: 19284173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical Manufacturing in the EU and the EU-US Mutual Recognition Agreement.
    Gaspar Ernesto LM; Dias Loureiro RM
    PDA J Pharm Sci Technol; 2020; 74(6):617-626. PubMed ID: 32540862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of Blockchain Initiatives for Value-Based Care: Proposed Framework.
    Zhang R; George A; Kim J; Johnson V; Ramesh B
    J Med Internet Res; 2019 Sep; 21(9):e13595. PubMed ID: 31573899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new definition of pharmaceutical quality: assembly of a risk simulation platform to investigate the impact of manufacturing/product variability on clinical performance.
    Short SM; Cogdill RP; D'Amico F; Drennen JK; Anderson CA
    J Pharm Sci; 2010 Dec; 99(12):5046-59. PubMed ID: 20574996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance Measurement System and Quality Management in Data-Driven Industry 4.0: A Review.
    Tambare P; Meshram C; Lee CC; Ramteke RJ; Imoize AL
    Sensors (Basel); 2021 Dec; 22(1):. PubMed ID: 35009767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Green Synthetic Chemistry from a Pharmaceutical Perspective.
    Ahsan H; Islam SU; Ahmed MB; Lee YS; Sonn JK
    Curr Pharm Des; 2020; 26(45):5767-5782. PubMed ID: 32988346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Industrial Structure Upgrade on Coupling and Coordinated Development-Empirical Analysis From Chinese Pharmaceutical Manufacturing and Pharmaceutical Service Industries.
    Hu M; Tao C; Zhou H
    Front Public Health; 2021; 9():722006. PubMed ID: 34604159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decentralized Machine Autonomy for Manufacturing Servitization.
    Pustišek M; Chen M; Kos A; Kos A
    Sensors (Basel); 2022 Jan; 22(1):. PubMed ID: 35009881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockchain in manufacturing quality control: A computer simulation study.
    Wong PM; R K Sinha S; Chui CK
    PLoS One; 2021; 16(3):e0247925. PubMed ID: 33647047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing pharmacy and healthcare with virtual digital technologies.
    Trenfield SJ; Awad A; McCoubrey LE; Elbadawi M; Goyanes A; Gaisford S; Basit AW
    Adv Drug Deliv Rev; 2022 Mar; 182():114098. PubMed ID: 34998901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.